Zobrazeno 1 - 10
of 32
pro vyhledávání: '"J E, Tcheng"'
Autor:
C L, Wagner, A, Schantz, E, Barnathan, A, Olson, M A, Mascelli, J, Ford, L, Damaraju, T, Schaible, R N, Maini, J E, Tcheng
Publikováno v:
Developments in biologicals. 112
The clinical consequences of immune antibodies generated to abciximab (ReoPro) and infliximab (Remicade) are described. Abciximab, a chimaeric Fab fragment that binds to the beta3 integrin of the GPIIb/IIIa and alphavbeta3 receptors on human platelet
Publikováno v:
Minerva cardioangiologica. 50(5)
Percutaneous coronary angioplasty and stenting is widely used for the treatment of patients with coronary artery disease. Glycoprotein (GP) IIb-IIIa inhibitors represent a new class of drugs with proven efficacy in reducing ischemic complications of
Autor:
C M, Gibson, D J, Cohen, E A, Cohen, H K, Lui, S A, Murphy, S J, Marble, M, Kitt, T, Lorenz, J E, Tcheng
Publikováno v:
The American journal of cardiology. 87(11)
Autor:
J F, Tanguay, W J, Cantor, M W, Krucoff, B, Muhlestein, G W, Barsness, J P, Zidar, M H, Sketch, J E, Tcheng, H R, Phillips, R S, Stack, A V, Kaplan, E M, Ohman
Publikováno v:
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac AngiographyInterventions. 49(4)
Bailout stenting for major dissection and threatened closure has high rates of ischemic complications. We performed a randomized trial of local heparin delivery using the infusion sleeve before bailout stenting for suboptimal angioplasty results. In
Autor:
J C, O'Shea, J E, Tcheng
Publikováno v:
Journal of thrombosis and thrombolysis. 10(3)
Publikováno v:
The Journal of invasive cardiology. 12(11)
To determine the effects of the incidental exposure of stents to pulsed 308 nanometer ultraviolet excimer laser energy.Five types of 316 L stainless-steel coronary stents were subjected to two types of study. First, for endurance testing, sixty stent
Publikováno v:
The Journal of invasive cardiology. 12(10)
Autor:
A M, Lincoff, L A, LeNarz, G J, Despotis, P K, Smith, J E, Booth, R E, Raymond, S K, Sapp, C F, Cabot, J E, Tcheng, R M, Califf, M B, Effron, E J, Topol
Publikováno v:
The Annals of thoracic surgery. 70(2)
Abciximab during percutaneous coronary revascularization reduces ischemic complications, but concern exists regarding increased bleeding risk should emergency coronary surgical procedures be required.Outcomes were assessed among 85 patients who requi
Autor:
L, Cho, E J, Topol, C, Balog, J M, Foody, J E, Booth, C, Cabot, N S, Kleiman, J E, Tcheng, R, Califf, A M, Lincoff
Publikováno v:
Journal of the American College of Cardiology. 36(2)
We sought to determine the efficacy and safety of platelet glycoprotein IIb/IIIa receptor (GP IIb/IIIa) blockade with abciximab in women undergoing percutaneous coronary intervention.Although gender differences in response to platelet glycoprotein II
Autor:
C, O'Shea, J E, Tcheng
Publikováno v:
The Journal of invasive cardiology. 11(8)